In various embodiments of the present disclosure, compositions are described herein that comprise a substituted pyridine compound in combination with a chemosensory irritant, a flavoring agent, an organic acid, and/or a solvent. Such compositions can be in the form of a solution, a powder and/or a granulate with a carrier, and/or the like. A series of compositions having decreasing (w/v) amounts of substituted pyridine compound can be provided as part of a smoking cessation program.
C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24B 15/30 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
2.
VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF
In various embodiments of the present disclosure, vaporizable alkaloid compositions comprising a substituted pyridine compound of Formula (I) and entirely absent nicotine are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. A series of such vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24B 15/30 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
3.
TOBACCO HARM REDUCTION AND PAIN RELIEF PRODUCTS AND METHODS THEREOF
Tobacco harm reduction (THR) products according to the present disclosure include both dermally and orally administered products, each comprising at least one substituted pyridine compound according to Formula (I), with excipients and optional substrate customized to a physical form or a function of the product. In various examples, THR products include (a) a transdermal patch, (b) a dissolving film, (c) a lozenge, (d) a chewing gum, (e) an oral pouch, (f) impregnated toothpicks, (g) impregnated or coated dental floss, (h) a mouthwash, (i) a gummy candy, (j) sublingual disintegrating tablets, or (k) a topical/transdermal cream.
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24B 15/30 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
A61K 31/4025 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
Tobacco harm reduction (THR) products according to the present disclosure include both dermally and orally administered products, each comprising at least one substituted pyridine compound according to Formula (I), with excipients and optional substrate customized to a physical form or a function of the product. In various examples, THR products include (a) a transdermal patch, (b) a dissolving film, (c) a lozenge, (d) a chewing gum, (e) an oral pouch, (f) impregnated toothpicks, (g) impregnated or coated dental floss, (h) a mouthwash, (i) a gummy candy, (j) sublingual disintegrating tablets, or (k) a topical/transdermal cream.
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24F 47/00 - Smokers’ requisites not otherwise provided for
A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
A61K 31/5377 - 1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
5.
VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF
In various embodiments of the present disclosure, vaporizable alkaloid compositions comprising a substituted pyridine compound of Formula (I) and entirely absent nicotine are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. A series of such vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
In various embodiments of the present disclosure, vaporizable alkaloid compositions comprising a substituted pyridine compound of Formula (I) and entirely absent nicotine are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. A series of such vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24B 15/30 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
A24B 15/38 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero-atoms
7.
VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF
In various embodiments of the present disclosure, vaporizable alkaloid compositions comprising a substituted pyridine compound of Formula (I) and entirely absent nicotine are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. A series of such vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
C07D 401/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
C07D 413/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
8.
Vaporizable alkaloid compositions and methods of use thereof
In various embodiments of the present disclosure, vaporizable alkaloid compositions are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. The compositions herein comprise a substituted pyridine compound in combination with a chemosensory irritant, which in certain examples comprises a spice additive having a spiciness of from about 1,000 to about 20,000,000 Scoville Heat Units (SHU). A series of vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24B 15/30 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
9.
VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF
In various embodiments of the present disclosure, vaporizable alkaloid compositions comprising a substituted pyridine compound of Formula (I) and entirely absent nicotine are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. A series of such vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
C07D 401/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
C07D 413/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
10.
VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF
In various embodiments of the present disclosure, vaporizable alkaloid compositions comprising a substituted pyridine compound of Formula (I) and entirely absent nicotine are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. A series of such vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24B 15/30 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
A24B 15/38 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero-atoms
11.
Vaporizable alkaloid compositions and methods of use thereof
In various embodiments of the present disclosure, vaporizable alkaloid compositions are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. The compositions herein comprise a substituted pyridine compound in combination with a chemosensory irritant, which in certain examples comprises a spice additive having a spiciness of from about 1,000 to about 20,000,000 Scoville Heat Units (SHU). A series of vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24B 15/30 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
12.
VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF
In various embodiments of the present disclosure, vaporizable alkaloid compositions are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. The compositions herein comprise a substituted pyridine compound in combination with a chemosensory irritant, which in certain examples comprises a spice additive having a spiciness of from about 1,000 to about 20,000,000 Scoville Heat Units (SHU). A series of vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24B 15/16 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
A61K 31/395 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A24B 15/10 - Chemical features of tobacco products or tobacco substitutes
In various embodiments of the present disclosure, vaporizable alkaloid compositions are described that are capable of forming an inhalable vapor when dispensed from an electronic device such as an e-cigarette. The compositions herein comprise a substituted pyridine compound in combination with a chemosensory irritant, which in certain examples comprises a spice additive having a spiciness of from about 1,000 to about 20,000,000 Scoville Heat Units (SHU). A series of vaporizable alkaloid compositions having decreasing (w/v) amounts of substituted pyridine compound are provided as part of a smoking cessation program.
C07D 401/00 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
A24B 15/167 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A24B 15/30 - Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
34 - Tobacco; smokers' articles
Goods & Services
Chemicals for use in the manufacture of nicotine substitute electronic cigarette liquid, nicotine substitute pouches as snus substitutes, and nicotine substitute lozenges for smoking cessation Lozenges for smoking cessation containing a nicotine substitute, to temporarily reduce the desire to smoke Electronic cigarette liquid (e-liquid) comprised of vegetable glycerin containing a nicotine substitute; nicotine substitute pouches as a substitute for snus
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
34 - Tobacco; smokers' articles
Goods & Services
Chemicals for use in the manufacture of nicotine substitute electronic cigarette liquid, nicotine substitute pouches as snus substitutes, and nicotine substitute lozenges for smoking cessation Lozenges for smoking cessation containing a nicotine substitute, to temporarily reduce the desire to smoke Electronic cigarette liquid (e-liquid) comprised of vegetable glycerin containing a nicotine substitute; nicotine substitute pouches as a substitute for snus
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
34 - Tobacco; smokers' articles
Goods & Services
Chemicals for use in the manufacture of nicotine substitute electronic cigarette liquid, nicotine substitute pouches as snus substitutes, and nicotine substitute lozenges for smoking cessation Lozenges for smoking cessation containing a nicotine substitute, to temporarily reduce the desire to smoke Electronic cigarette liquid (e-liquid) comprised of vegetable glycerin containing a nicotine substitute; nicotine substitute pouches as a substitute for snus